Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Actuate Therapeutics, Inc. (ACTU)

NASDAQ

$1.02

$+0.00

(+0.49%)

Pre-Market

Actuate Therapeutics, Inc. (ACTU) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Actuate Therapeutics, Inc. (ACTU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.02, with a market capitalisation of $24.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.90 to $8.49. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$24.73M
Open	$1.01
Day's High	$25.55
Day's Low	$0.90
Previous Close	$0.98
Volume	--
Average Volume	368.35K
P/E Ratio	--
52-Week High	$8.49
52-Week Low	$0.90
Dividend Yield	--
Earnings Date	--

Actuate Therapeutics, Inc. (ACTU) Pre-Market Stock Price

Actuate Therapeutics, Inc. (ACTU) is trading at $1.02 in pre-market trading as of 2026-09-16 09:36:00, up 3.59% ($0.04) from the previous close of $0.98

Pre-market trading shows how investors are pricing ACTU before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Actuate Therapeutics, Inc. (ACTU) 7-Day Stock Price Change

Over the past seven days, Actuate Therapeutics, Inc. (ACTU) moved from $1.48 to $1.02, representing a decline of 31.15% ($0.46).

The stock traded between $0.98 and $1.73 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 358.49 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ACTU 52-Week Price Position

Position in Range: 1.6%

52W Low$0.90

52W High$8.49

ACTU is currently trading at $1.02, placing it 1.6% of the way from its 52-week low of $0.90 to its 52-week high of $8.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Actuate Therapeutics, Inc. (ACTU)?

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Actuate Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	12
Exchange	NASDAQ
Company Website	https://www.actuatetherapeutics.com

How to Buy Actuate Therapeutics, Inc. (ACTU) Stock on MEXC

Eligible investors can buy real shares of Actuate Therapeutics, Inc. (ACTU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ACTU and Place Your Order

Open the RealStocks trading page and search for ACTU. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Actuate Therapeutics, Inc. (ACTU) stock price today?

Actuate Therapeutics, Inc. (ACTU) is currently trading at $ 1.02, up 3.59% ($0.04) from the previous close of $ 0.98. Intraday prices update in real time during regular trading hours.

2.Is ACTU stock going up or down today?

As of 2026-09-16 09:36:00, ACTU is trading at $ 1.02, up 3.59% ($0.04) from its previous close of $ 0.98. The stock has traded between $ 0.90 and $ 25.55 during today’s regular session. Past price movements do not guarantee future results.

3.What is ACTU pre-market price?

As of 2026-09-16 09:36:00, ACTU is trading at $ 1.02 in pre-market trading, up 3.59% ($0.04) from the previous close of $ 0.98. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ACTU after-hours price?

As of 2026-09-16 09:36:00, ACTU is trading at $ 1.01 in after-hours trading, up 2.98% ($0.03) from the regular-session close of $ 0.98. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ACTU stock trading now?

ACTU trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ACTU sit relative to its 52-week high and low?

Over the past 52 weeks, ACTU has traded between a low of $ 0.90 and a high of $ 8.49. At $ 1.02, the stock is positioned 1.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Actuate Therapeutics, Inc. in?

Actuate Therapeutics, Inc. (ACTU) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Actuate Therapeutics, Inc.'s market capitalisation and where is it listed?

Actuate Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 24.73M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ACTU valued in terms of P/E ratio and EPS?

ACTU trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.85. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Actuate Therapeutics, Inc. pay a dividend?

Actuate Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.